Repeat surgery for prolapse (stage 2 or greater) at 2 years · women with anterior compartment pelvic organ prolapse
It is very uncertain whether anterior prolapse repair: native tissue changes repeat surgery for prolapse (stage 2 or greater) at 2 years compared with absorbable mesh (very low certainty).
1 finding from 1 review
Surgery for recurrent prolapse · women with anterior compartment pelvic organ prolapse
Anterior prolapse repair: native tissue showed no clear difference in repeat surgery for prolapse (1‐2 years) compared with biological graft (moderate certainty).
1 finding from 1 review
Repeat surgery ‐ prolapse review 1 to 3 years · women with anterior compartment pelvic organ prolapse
Anterior prolapse repair: native tissue probably leads to higher repeat surgery for prolapse (1‐3 years) compared with polypropylene mesh (moderate certainty).
1 finding from 1 review
Repeat surgery for stress urinary incontinence (2 years) · women with anterior compartment pelvic organ prolapse
Anterior prolapse repair: native tissue showed no clear difference in repeat surgery for stress urinary incontinence (1‐2 years) compared with polypropylene mesh (low certainty).
1 finding from 1 review
Intervention not reported
Poor visual outcome after surgery: best‐corrected visual acuity of < 6/60 at 6‐8 weeks. · people with age‐related cataract
1 finding from 1 review
Intervention not reported
Long‐term complications (one year or more after surgery) · people with age‐related cataract
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Posterior capsule opacification 12 months after surgery · people with age‐related cataract
1 finding from 1 review
Intervention not reported
Adverse events: cataract surgery at 1 year · patients with choroidal neovascularisation secondary to age‐related macular degeneration
The intervention leads to higher adverse events: cataract surgery at 1 year (high certainty).
1 finding from 1 review
Length of postoperative hospital stay · women with gynaecological cancers
1 finding from 1 review
Overall postoperative complications (within 30 days of operation) · women with gynaecological cancers
Enhanced recovery after surgery programme showed no clear difference in overall postoperative complications (within 30 days of operation) compared with traditional care (low certainty).
1 finding from 1 review
Mortality (within 30 days of discharge) · women with gynaecological cancers
It is very uncertain whether enhanced recovery after surgery programme changes mortality (within 30 days of discharge) compared with traditional care (very low certainty).
1 finding from 1 review
Patient readmissions · women with gynaecological cancers
Enhanced recovery after surgery programme may leads to lower readmission (within 30 days of operation) compared with traditional care (low certainty).
1 finding from 1 review
Time from completion of operation to first flatus (hours) · women with gynaecological cancers
1 finding from 1 review
Time from completion of operation to first bowel movement (hours) · women with gynaecological cancers
1 finding from 1 review
Participant satisfaction · women with gynaecological cancers
1 finding from 1 review
Economic outcomes · women with gynaecological cancers
1 finding from 1 review
Mean postoperative surgically induced astigmatism · people with age‐related cataract
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Mean postoperative best‐corrected visual acuity · people with age‐related cataract
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Mean change of endothelial cell loss · people with age‐related cataract
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Central corneal thickness · people with age‐related cataract
1 finding from 1 review
no estimate extracted
Studies not reported
Low